Protea Biosciences, Inc.'s Breakthrough Bioanalytics Platform Receives Prestigious 2012 R&D 100 Award  
6/21/2012 9:37:46 AM

MORGANTOWN, W.Va., June 21, 2012 (GLOBE NEWSWIRE) -- Protea Biosciences Group, Inc. ("Protea"), a leading developer of technologies and services for biomolecular analysis, announced today that its LAESI(R) DP-1000 direct ionization system has been selected by an independent judging panel and the editors of R&D Magazine to receive a 2012 R&D 100 Award. The LAESI DP-1000 was hailed by R&D Magazine as one of the 100 most technologically significant products introduced in the past year.